Kala Bio delays quarterly report to complete liquidity analysis
KALA•Kala Bio will delay its Form 10-Q for the quarter ended September 30, 2026, while it analyzes liquidity and capital resources. It expects to file within five calendar days of the deadline and anticipates no significant year-over-year change in operating results.
1. Filing delay
Kala Bio said it will delay its Form 10-Q for the quarter ended September 30, 2026, pending analysis of its liquidity and capital resources. The company expects to file within five calendar days of the prescribed deadline and does not anticipate a significant year-over-year change in operating results.
